Literature DB >> 2882788

Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.

M S Buchsbaum, J C Wu, L E DeLisi, H H Holcomb, E Hazlett, K Cooper-Langston, R Kessler.   

Abstract

Glucose metabolic rate in the basal ganglia, thalamus, and somatosensory cortex was examined in eight patients with schizophrenia before and after receiving neuroleptic medication. Basal ganglia metabolic rates were increased with medication: more on the right than on the left and more in putamen than caudate. The cortical anteroposterior ratio, an index of relative hypofrontality, was not affected by neuroleptics. The brain areas that were found to be altered by neuroleptics were selected for comparison between off-medication schizophrenics and controls. Metabolic rates in the basal ganglia tended to be low in patients with schizophrenia in comparison to 24 age- and sex-matched controls.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882788     DOI: 10.1016/0006-3223(87)90170-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  22 in total

Review 1.  Functional brain mapping of psychopathology.

Authors:  G D Honey; P C Fletcher; E T Bullmore
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 2.  Predictors and markers of clozapine response.

Authors:  Carmen Chung; Gary Remington
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

3.  Brief report: attention performance in autism and regional brain metabolic rate assessed by positron emission tomography.

Authors:  M S Buchsbaum; B V Siegel; J C Wu; E Hazlett; N Sicotte; R Haier; P Tanguay; R Asarnow; T Cadorette; D Donoghue
Journal:  J Autism Dev Disord       Date:  1992-03

4.  Comparison of Classical and Clozapine Treatment on Schizophrenia Using Positive and Negative Syndrome Scale of Schizophrenia (PANSS) and SPECT Imaging.

Authors:  Mohammad Sharafi
Journal:  Int J Med Sci       Date:  2005-05-10       Impact factor: 3.738

Review 5.  Structural and functional brain imaging in schizophrenia.

Authors:  J M Cleghorn; R B Zipursky; S J List
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

6.  Regional cerebral blood flow in patients with schizophrenia. A preliminary report.

Authors:  Y Kawasaki; M Suzuki; Y Maeda; K Urata; N Yamaguchi; H Matsuda; K Hisada; M Suzuki; T Takashima
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

7.  Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.

Authors:  M Soyka; W Koch; H J Möller; T Rüther; K Tatsch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-18       Impact factor: 5.270

8.  Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride.

Authors:  C J Bench; A A Lammertsma; R J Dolan; P M Grasby; S J Warrington; K Gunn; M Cuddigan; D J Turton; S Osman; R S Frackowiak
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  A test-retest study of cerebral blood flow during somatosensory stimulation in depressed patients with schizophrenia and major depression.

Authors:  D Ebert; H Feistel; A Barocka; W Kaschka; T Mokrusch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

10.  Multimodal neuroimaging studies and neurodevelopment and neurodegeneration hypotheses of schizophrenia.

Authors:  Vicente Molina; Santiago Reig; Manuel Desco; Juan D. Gispert; Javier Sanz; Fernando Sarramea; Javier Pascau; Carlos Benito; Raul Martínez-Lázaro; Rogelio Luque; María Aragües; Jose M. Misiego; Ignacio López Corral; Thomás Palomo
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.